Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Alzheimer Disease and Associated Disorders|December 14, 2004
Reliability of monitoring the clinical dementia rating in multicenter clinical trialsKimberly A Schafer, Rochelle E Tractenberg, Mary Sano, et al.
Neurology|April 4, 2014
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer diseaseDouglas Galasko, Joanne Bell, Jessica Y Mancuso, et al.
JAMA Neurology|March 28, 2018
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical TrialMichael S Rafii, Mark H Tuszynski, Ronald G Thomas, et al.
Alzheimer Disease and Associated Disorders|July 3, 2009
MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study populationRema Raman, Ronald G Thomas, Michael W Weiner, et al.
JAMA Neurology|June 3, 2014
The preclinical Alzheimer cognitive composite: measuring amyloid-related declineMichael C Donohue, Reisa A Sperling, David P Salmon, et al.
Journal of the International Neuropsychological Society : JINS|August 26, 2004
A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's diseaseJoanne M Hamilton, David P Salmon, Douglas Galasko, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's diseaseDavid Gelmont, Ronald G Thomas, Jonathan Britt, et al.
Neuropsychology|July 24, 2013
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderlyDavid P Salmon, Steven H Ferris, Ronald G Thomas, et al.
Alzheimer Disease and Associated Disorders|December 1, 2006
ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderlyMary Sano, Carolyn W Zhu, Peter J Whitehouse, et al.
Pageof 9